Rein TherapeuticsRNTX
13F holders, Q4 2024 (December 31)31holders
6new positions
8sold out
$2.30avg. 13F price*
At the end of Q4 2024, 31 institutions reported holding Rein Therapeutics Inc. (RNTX) in their 13F filings, unchanged from Q3 2024. 6 opened new positions and 8 sold out. The largest holders were BIOS Capital Management, LP ($3.9M), Voss Capital, LP ($2.2M) and University of Texas/Texas Am Investment Management Co. ($1.4M).
- Company
- Rein Therapeutics Inc.
- Filed as
- AILERON THERAPEUTICS INC (Q4 2024)
- CUSIP
- 00887A204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $2.3M |
| Exits | 8 | $3.8M |
All 13F filers, Q3 2024 → Q4 2024: 1,218,079 shares bought and 1,857,200 shares sold, net −639,121 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| BIOS Capital Management, LP | 4.13% | — | 1,690,751 | $3.9M |
| Voss Capital, LP | 0.16% | New | 956,195 | $2.2M |
| University of Texas/Texas Am Investment Management Co. | 0.17% | Reduce -56.0% | 617,121 | $1.4M |
| Vanguard Group Inc. | 0.00% | Reduce -1.7% | 424,994 | $977K |
| Cable Car Capital, LP | 0.07% | No change | 420,000 | $966K |
| Prosight Management, LP | 0.26% | Add +8.8% | 404,979 | $931K |
| Geode Capital Management, LLC | 0.00% | Add +5.1% | 241,437 | $555K |
| Sigma Planning Corp | 0.02% | Add +11.2% | 236,210 | $543K |
| Senvest Management, LLC | 0.02% | No change | 230,895 | $531K |
| Royal Bank of Canada | 0.00% | Add +1237.2% | 106,972 | $246K |
| BlackRock, Inc. | 0.00% | Add +54.0% | 78,953 | $182K |
| Gagnon Securities LLC | 0.03% | Reduce -0.0% | 71,745 | $165K |
| Exencial Wealth Advisors, LLC | 0.00% | New | 30,528 | $70K |
| Texas Capital Bank Wealth Management Services Inc | 0.01% | No change | 26,171 | $60K |
| Northern Trust Corp. | 0.00% | No change | 25,763 | $59K |
| Blair William & Co. | 0.00% | No change | 25,602 | $59K |
| KCK LTD. | 0.07% | — | 22,341 | $51K |
| KG Capital Management | 0.01% | Add +38.5% | 18,000 | $41K |
| XTX Topco Ltd | 0.00% | New | 16,038 | $37K |
| State Street Corp. | 0.00% | Add +53.8% | 16,004 | $37K |
| UBS Group AG | 0.00% | New | 7,251 | $17K |
| Morgan Stanley | 0.00% | Reduce -22.5% | 4,300 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +961.7% | 2,580 | $6K |
| JFS Wealth Advisors, LLC | 0.00% | No change | 1,590 | $4K |
| US Bancorp \de | 0.00% | No change | 1,250 | $3K |
| Sachetta, LLC | 0.00% | No change | 1,000 | $2K |
| Bank of America Corp. | 0.00% | Reduce -0.3% | 284 | $654 |
| Hexagon Capital Partners LLC | 0.00% | New | 213 | $490 |
| JPMorgan Chase & Co. | 0.00% | New | 30 | $69 |
| Game Plan Financial Advisors, LLC | 0.00% | No change | 25 | $56 |
| Acadian Asset Management LLC | 0.00% | No change | 17 | $0 |
"% of holder's portfolio" is RNTX's weight in each manager's 13F, not the share of Rein Therapeutics Inc. the manager owns.